Given tissue-specific enhancer and CTCF chromatin landscapes as well as cancer dependency genes, the epigenetic consequences of IDH1 mutation in CAC and its interplay with inflammation will be an exciting area of future study [10, 77]. The gene discussed is IDH1; the disease is cancer.